Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

The following is a summary of “Pediatric Attention-Deficit/Hypearativity Disorder and Disruptive Mood Dysregulation Disorder: ...

Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

ADHD is a common neurodevelopment condition that affects how children think, learn and interact. It impacts 5-8 per cent of ...

The new guidelines also advise healthcare professionals to ask questions about gambling in various situations, including ...

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

GPs should ask patients who may be at risk of gambling-related harms about their habits, according to a new NICE clinical ...

Attention-deficit/hyperactivity disorder (previously known as attention deficit disorder or ADD) is a neurobehavioral disorder characterized by core symptoms of ...

The research carried out by University College London (UCL) revealed that individuals with Attention Deficit Hyperactivity Disorder (ADHD ... the right support and treatment.

Healthcare professionals should consider asking people about gambling when speaking to them about smoking and alcohol consumption during a health check or GP appointment, new guidance recommends.

A group of Estonian psychiatrists and civic activists believe that allowing the therapeutic use of currently prohibited ...